679 A PILOT STUDY OF ZR89-J591 POSITRON EMISSION TOMOGRAPHY (PET) IMAGING IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY

2013 ◽  
Vol 189 (4S) ◽  
Author(s):  
David Green ◽  
Shoaib B. Fareedy ◽  
Joseph R. Osborne ◽  
Brian D. Robinson ◽  
Sagit Goldenberg ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Positron Emission Tomography ◽  
Pilot Study ◽  
Radical Prostatectomy ◽  
Pet Imaging ◽  
Emission Tomography ◽  
Positron Emission

scholarly journals Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men

Theranostics ◽  
2014 ◽  
Vol 4 (4) ◽  
pp. 412-419 ◽  
Author(s):  
Gesche Wieser ◽  
Rosalba Mansi ◽  
Anca L. Grosu ◽  
Wolfgang Schultze-Seemann ◽  
Rebecca A. Dumont-Walter ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Positron Emission Tomography ◽  
Receptor Antagonist ◽  
Pet Imaging ◽  
Emission Tomography ◽  
Peptide Receptor ◽  
Gastrin Releasing Peptide ◽  
Positron Emission

scholarly journals 68Gallium-prostate-specific membrane antigen ligand positron-emission tomography or computed tomography in biochemical failure after radical prostatectomy: A case report

2017 ◽  
Vol 1 ◽  
pp. 3
Author(s):  
Irene A. Chidothe ◽  
David B. Anderson
Keyword(s):  
Prostate Cancer ◽  
Computed Tomography ◽  
Positron Emission Tomography ◽  
Case Report ◽  
Radical Prostatectomy ◽  
Biochemical Failure ◽  
Emission Tomography ◽  
Prostate Specific Membrane Antigen ◽  
Positron Emission ◽  
Specific Membrane

Biochemical failure after radical treatment for prostate cancer occurs in up to 30% – 50% of cases. Localisation of clinical disease is challenging because clinical symptoms often manifest long after the initial rise in prostate-specific antigen. The detection rates of imaging modalities such as contrasted computed tomography (CT), bone scan, magnetic resonance imaging and choline positron-emission tomography (PET) or CT, are limited. Prostate-specific membrane antigen (PSMA) ligand PET or CT is a novel imaging modality under investigation for various diagnostic and therapeutic indications in the management of prostate cancer. We present a case report illustrating how <sup><span style="font-size: small;">68</span></sup>Gallium-PSMA ligand PET or CT was used to guide management in a patient presenting with biochemical failure after radical prostatectomy.

[18F]choline positron emission tomography in prostate cancer patients with biochemical recurrence after radical prostatectomy

2012 ◽  
Vol 33 (8) ◽  
pp. 889-894 ◽  
Author(s):  
Benjamin Henninger ◽  
Peter Vesco ◽  
Daniel Putzer ◽  
Dorota Kendler ◽  
Alexander Loizides ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Positron Emission Tomography ◽  
Radical Prostatectomy ◽  
Cancer Patients ◽  
Biochemical Recurrence ◽  
Emission Tomography ◽  
Positron Emission
Sign in / Sign up

Export Citation Format

Share Document